Complexes of technetium-99 m with tetrapeptides containing one alanyl and three glycyl moieties

European Journal of Nuclear Medicine

Volumn 23, Issue 1, 1996, Pages 40-48

  Vanbilloen, Hubert P ^a   De Roo, Michel J ^b   Verbruggen, Alfons M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Renal tracer agent; Technetium 99m mercaptoacetyltriglycine; Technetium 99m tetrapeptides

Indexed keywords

AMINO ACID; MERTIATIDE TC 99M; METHYL GROUP; TECHNETIUM 99M; TETRAPEPTIDE;

ALKALINITY; ANIMAL EXPERIMENT; ARTICLE; BABOON; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; LIVER; MOUSE; NONHUMAN; NORMAL HUMAN; PLASMA CLEARANCE; RENOGRAPHY; URINARY EXCRETION;

ANIMALS; ETHYLENEDIAMINES; HUMANS; INTESTINES; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; KIDNEY; LIVER; MALE; MICE; MICE, INBRED STRAINS; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; PAPIO; STRUCTURE-ACTIVITY RELATIONSHIP; TECHNETIUM; TECHNETIUM TC 99M MERTIATIDE; TISSUE DISTRIBUTION;

EID: 0030067431     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01736988     Document Type: Article

References (21)

1. 3 as a hippuran replacement. J Nucl Med 1986; 27: 111-116.
2. 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF). Nucl Med Commun 1989; 10: 99-107.
3. Lee H-B, Blaufox MD. Technetium-99m MAG-3 clearances after captopril in experimental renovascular hypertension. J Nucl Med 1989; 30: 666-671.
4. 3 with iodine-131 hippuran by a simultaneous dual channel technique. J Nucl Med 1988; 29: 1189-1193.
5. 131I labeled sodium iodohippurate in kidney function tests. Proc Soc Exp Biol Med 1960; 103: 497-498.
6. Schwartz FD, Madeloff MS. Simultaneous renal clearances of radiohippuran and PAH in man [abstract]. Clin Res 1961; 9: 208.
7. Burbank MK, Tauxe WN, Moher F, Hunt JC. Evaluation of radioiodinated hippuran for the estimation of renal plasma flow. Proc Staff Meet Mayo Clin 1961; 36: 372-386.
8. 3 by simultaneous double tracer measurement. Nuc Compact 1986; 17: 135-138.
9. Vanbilloen H, Van Nerom C, Bormans G, Subhani M, De Roo M, Verbruggen A. Labelling of glycylalanyldiglycine with Tc-99m and study of biodistribution in mice. Eur J Nucl Med 1990; 16: 539.
10. Vanbilloen H, Bormans G, Heylen J, Hoogmartens M, De Roo M, Verbruggen A. Complexes of technetium-99m with tetraglycine and tetra-L-alanine and their biodistribution in mice. J Labelled Compd Radiopharm 1991; 30: 42-44
11. Bormans G, Vanbilloen H, Van Nerom C, Heylen J, Hoogmartens M, De Roo M, Verbruggen A. Complexes of technetium-99m with alanyltriglycine: labelling and biological characteristics of the respective isomers. In: Schmidt HAE, van der Schoot JB (eds) Nuclear medicine. The state of the art of nuclear medicine in Europe. Stuttgart New York: Schattauer; 1991: 121-123.
12. 99mTc-labelled agents. Nucl Med Biol 1995; 22: 325-338.
13. 99mTc-mercaptoacetyltripeptides in mice and baboon. Nucl Med Biol 1992; 19: 375-388.
14. Bormans GM, Cleynhens BJ, De Roo MJK, Verbruggen AM. Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers. Eur J Nucl Med 1992; 19: 271-277.
15. Greenstein JP, Winitz M. Chemistry of the amino acids. Malabar, Fl.: Krieger, 1984.
16. Verbruggen AM, Nosco DL, Van Nerom CG, Bormans GM, Adriaens PJ, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labelling and evaluation in animals. J Nucl Med 1992; 33: 551-557.
17. Vanbilloen H. Complexes of technetium-99m with derivatives of mercaptoacetyltriglycine. PhD Thesis, Leuven Faculty of Pharmaceutical Sciences, K.U. Leuven; 1994: 126-137.
18. 99mTc-mercaptoacetyltripeptides. J. Labelled Compd Radiopharm 1993; 33: 1065-1078.
19. Verbruggen AM. Radiopharmaceuticals: state of the art. Eur J Nucl Med 1990; 17: 346-364.
20. Despopoulos A. A definition of substrate specificity in renal transport of organic anions. J Theoret Biol 1965; 8: 163-192.
21. 99mTc-mercaptoacetlyglycyl-L-alanylglycine-B in mice and baboon. J Nucl Med All Sci 1989; 33: 275-276.